NO20063461L - Nye polysubstituert 1,1-pyridyloksycyklopropanaminforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem - Google Patents

Nye polysubstituert 1,1-pyridyloksycyklopropanaminforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Info

Publication number
NO20063461L
NO20063461L NO20063461A NO20063461A NO20063461L NO 20063461 L NO20063461 L NO 20063461L NO 20063461 A NO20063461 A NO 20063461A NO 20063461 A NO20063461 A NO 20063461A NO 20063461 L NO20063461 L NO 20063461L
Authority
NO
Norway
Prior art keywords
pyridyloxycyclopropanamine
compounds
preparation
methods
pharmaceutical compositions
Prior art date
Application number
NO20063461A
Other languages
English (en)
Norwegian (no)
Inventor
Brian Lockhart
Pierre Lestage
Solo Goldstein
Claude Guillonneau
Yves Charton
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20063461L publication Critical patent/NO20063461L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20063461A 2005-07-28 2006-07-27 Nye polysubstituert 1,1-pyridyloksycyklopropanaminforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO20063461L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0508033A FR2889187B1 (fr) 2005-07-28 2005-07-28 Nouveaux composes 1,1-pyridinyloxycyclopropanamines polysusbstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
NO20063461L true NO20063461L (no) 2007-01-29

Family

ID=35841768

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063461A NO20063461L (no) 2005-07-28 2006-07-27 Nye polysubstituert 1,1-pyridyloksycyklopropanaminforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (27)

Country Link
US (1) US7348344B2 (es)
EP (1) EP1748043B1 (es)
JP (1) JP2007077135A (es)
KR (1) KR100824830B1 (es)
CN (1) CN100519531C (es)
AR (1) AR054875A1 (es)
AT (1) ATE405550T1 (es)
AU (1) AU2006203241A1 (es)
BR (1) BRPI0603064A (es)
CA (1) CA2552827A1 (es)
DE (1) DE602006002328D1 (es)
DK (1) DK1748043T3 (es)
EA (1) EA011126B1 (es)
ES (1) ES2313589T3 (es)
FR (1) FR2889187B1 (es)
GE (1) GEP20084548B (es)
HR (1) HRP20080536T5 (es)
MA (1) MA28426B1 (es)
MX (1) MXPA06008415A (es)
NO (1) NO20063461L (es)
NZ (1) NZ548747A (es)
PL (1) PL1748043T3 (es)
PT (1) PT1748043E (es)
SG (1) SG129411A1 (es)
SI (1) SI1748043T1 (es)
WO (1) WO2007012762A1 (es)
ZA (1) ZA200606277B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2896800B1 (fr) * 2006-01-30 2008-04-11 Servier Lab Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
EA020506B1 (ru) * 2009-11-18 2014-11-28 Сувен Лайф Сайенсиз Лимитед БИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ЛИГАНДОВ αβНИКОТИНОВОГО АЦЕТИЛХОЛИНОВОГО РЕЦЕПТОРА

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2095350C1 (ru) * 1993-10-13 1997-11-10 Центр по химии лекарственных средств (ЦХЛС-ВНИХФИ) 3-(n,n-диметилкарбамоилокси)-2-этил-6-метилпиридина сукцинат, обладающий антигипоксической активностью
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
FR2810664B1 (fr) * 2000-06-27 2004-12-24 Adir Nouveaux composes cyclopropaniques 1,1 et 1,2-dissubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NZ548747A (en) 2007-06-29
AR054875A1 (es) 2007-07-25
CA2552827A1 (fr) 2007-01-28
EA200601248A1 (ru) 2007-04-27
MA28426B1 (fr) 2007-02-01
BRPI0603064A (pt) 2007-08-14
CN1903843A (zh) 2007-01-31
DE602006002328D1 (de) 2008-10-02
EP1748043B1 (fr) 2008-08-20
MXPA06008415A (es) 2007-01-29
JP2007077135A (ja) 2007-03-29
CN100519531C (zh) 2009-07-29
US7348344B2 (en) 2008-03-25
SG129411A1 (en) 2007-02-26
WO2007012762A1 (fr) 2007-02-01
EP1748043A1 (fr) 2007-01-31
SI1748043T1 (sl) 2008-12-31
PL1748043T3 (pl) 2008-12-31
HRP20080536T5 (en) 2009-03-31
US20070027191A1 (en) 2007-02-01
ATE405550T1 (de) 2008-09-15
HRP20080536T3 (en) 2009-02-28
KR100824830B1 (ko) 2008-04-23
AU2006203241A1 (en) 2007-02-15
DK1748043T3 (da) 2008-12-08
FR2889187A1 (fr) 2007-02-02
ES2313589T3 (es) 2009-03-01
GEP20084548B (en) 2008-11-25
FR2889187B1 (fr) 2007-09-07
ZA200606277B (en) 2007-04-25
PT1748043E (pt) 2008-10-07
KR20070015011A (ko) 2007-02-01
EA011126B1 (ru) 2008-12-30

Similar Documents

Publication Publication Date Title
CY1119669T1 (el) Παραγωγα 1-φαινυλ-2-πυριδινυλ-αλκυλ-αλκοολων ως αναστολεις φωσφοδιεστερασης
CY1120994T1 (el) Καινοτομες συνθεσεις διαλυματος που περιεχουν κυτταρικο παραγοντα και χρηση αυτων για τη θεραπεια τραυματων
UY28915A1 (es) Derivados de tetraazabenzo (e)azuleno y sus análogos
EA200970156A1 (ru) Пиридизиноновые производные
UA117800C2 (uk) Похідні урацилу або тиміну для лікування гепатиту с
CY1115893T1 (el) Anti-μολυσματικες πυριμιδινες και χρησεις αυτων
UA112281C2 (uk) Стабільні інсектицидні композиції і способи їх отримання
ECSP066317A (es) Compuestos
HRP20070043A2 (en) Antiviral compounds
CY1116339T1 (el) Πολυμορφικες μορφες ενος μακροκυκλικου αναστολεα hcv
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
UA96961C2 (uk) Азаадамантанові похідні і способи застосування
NO20090835L (no) Nye HIV-reverstranskriptaseinhibitorer
NO20061981L (no) Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist
NO20085214L (no) Nye pyridinanaloger
NO20073287L (no) 2,5 og 2,6-disubstituerte benzazol-analoger som proteinkinaseinhibitorer
CY1109637T1 (el) Νεα τρικυκλικα παραγωγα, η μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα περιεχουν
CY1113914T1 (el) Νεα παραγωγα διυδροϊνδολονων, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις οι οποιες τα περιεχουν
EA201070010A1 (ru) Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
NO20063461L (no) Nye polysubstituert 1,1-pyridyloksycyklopropanaminforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
EA200901030A1 (ru) Антагонист хроменового рецептора s1p1
ATE447575T1 (de) Selektive spirocyclische glucocorticoid-rezeptor- modulatoren
NO20080079L (no) AMPA-reseptorpotensiatorer
NO20100192L (no) Stabile salter av S-adenosylmetionin og fremgangsmater for fremstilling derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application